Boston Scientific Corporation vs Oatly Group AB - ADR — how do they compare? Boston Scientific Corporation trades at $51.17 (market cap $74.19B), while Oatly Group AB - ADR trades at $12.93 (market cap $415.98M). The key difference: Boston Scientific Corporation is far larger — about 178.3× Oatly Group AB - ADR's market cap, and Oatly Group AB - ADR is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | OTLY | |
|---|---|---|
Market Cap | $74.19B | $415.98M |
Sector | Health | Consumer Staples |
52-Week High | $108.14 | $18.54 |
52-Week Low | $42.63 | $8.03 |
Enterprise Value | $86.27B | $920.39M |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →